Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5690742 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
PID is associated with an increased risk of serous borderline tumors. Further research on the potential underlying biological mechanisms and on the identification of the subset of women with PID who are at increased risk of serous borderline tumors is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Christina B. Rasmussen, Allan Jensen, Vanna Albieri, Klaus K. Andersen, Susanne K. Kjaer,